We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+6.28%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.18B
AUM Growth
-$419M
Cap. Flow
-$653M
Cap. Flow %
-12.61%
Top 10 Hldgs %
12.12%
Holding
1,157
New
156
Increased
241
Reduced
474
Closed
210

Sector Composition

Rank Sector Weight
1 Technology 18.78%
2 Financials 17.57%
3 Healthcare 14.1%
4 Industrials 10.7%
5 Consumer Discretionary 9.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSII
326
DELISTED
Cardiovascular Systems, Inc.
CSII
$3.15M 0.06%
130,200
+83,392
+178% +$2.05M
CLW icon
327
Clearwater Paper
CLW
$271M
$3.15M 0.06%
48,014
-2,300
-5% -$142K
SCL icon
328
Stepan Co
SCL
$1.31B
$3.15M 0.06%
38,607
-1,228
-3% -$94.7K
TBI
329
Trueblue
TBI
$234M
$3.14M 0.06%
127,270
+63,773
+100% +$1.34M
PFGC icon
330
Performance Food Group
PFGC
$17.5B
$3.13M 0.06%
130,340
+18,687
+17% +$444K
ALGN icon
331
Align Technology
ALGN
$12B
$3.12M 0.06%
32,420
+4,030
+14% +$374K
SALE
332
DELISTED
RetailMeNot, Inc. Series 1
SALE
$3.1M 0.06%
333,499
-27,567
-8% -$258K
ABCO
333
DELISTED
Advisory Board Co
ABCO
$3.09M 0.06%
93,050
-73,388
-44% -$2.71M
EQR icon
334
Equity Residential
EQR
$25.4B
$3.09M 0.06%
48,060
+40,510
+537% +$2.49M
GHDX
335
DELISTED
Genomic Health, Inc.
GHDX
$3.08M 0.06%
104,670
+40,900
+64% +$1.25M
DCH
336
Dauch Corp
DCH
$1.3B
$3.07M 0.06%
158,893
+47,500
+43% +$805K
BW icon
337
Babcock & Wilcox
BW
$1.43B
$3.06M 0.06%
18,470
-1,564
-8% -$249K
TGNA
338
DELISTED
TEGNA Inc
TGNA
$3.05M 0.06%
+223,125
New +$3.04M
RF icon
339
Regions Financial
RF
$26.3B
$3.04M 0.06%
212,000
NTUS
340
DELISTED
Natus Medical Inc
NTUS
$3.03M 0.06%
+87,164
New +$3.42M
RYAM icon
341
Rayonier Advanced Materials
RYAM
$565M
$3M 0.06%
194,404
-63,090
-25% -$880K
BCC icon
342
Boise Cascade
BCC
$2.74B
$2.98M 0.06%
132,680
-62,332
-32% -$1.39M
NAVG
343
DELISTED
Navigators Group Inc
NAVG
$2.98M 0.06%
50,550
-400
-0.8% -$20.8K
GPN icon
344
Global Payments
GPN
$22.1B
$2.96M 0.06%
42,689
-48,936
-53% -$3.52M
DO
345
DELISTED
Diamond Offshore Drilling
DO
$2.95M 0.06%
+166,600
New +$2.94M
CRAY
346
DELISTED
Cray, Inc.
CRAY
$2.94M 0.06%
141,869
-16,410
-10% -$338K
OCLR
347
DELISTED
Oclaro Inc.
OCLR
$2.93M 0.06%
327,350
-181,412
-36% -$1.57M
XEL icon
348
Xcel Energy
XEL
$51B
$2.92M 0.06%
71,610
HOMB icon
349
Home BancShares
HOMB
$6.21B
$2.9M 0.06%
104,520
-2,420
-2% -$58.7K
ENOV icon
350
Enovis
ENOV
$1.56B
$2.89M 0.06%
46,772
-66,099
-59% -$3.91M

Similar funds

Jacobs Levy Equity Management's Q4 2016 Portfolio in Review

As of Q4 2016, Jacobs Levy Equity Management held 1,157 positions worth $5.18B, down 7.5% from $5.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Jacobs Levy Equity Management withdrew a net $653M in Q4 2016, closing 210 positions and reducing 474 holdings. Its most notable exit was Nike, an estimated $39.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Jacobs Levy Equity Management opened a new position in Express Scripts Holding Company worth $34.6M.

  • Jacobs Levy Equity Management's largest Q4 2016 buy was Express Scripts Holding Company: 502,999 shares worth $34.6M.
  • Jacobs Levy Equity Management added most to State Street SPDR S&P MIDCAP 400 ETF Trust in Q4 2016, an estimated $34.6M increase.
  • Jacobs Levy Equity Management's biggest Q4 2016 reduction was Alphabet (Google) Class C, cutting an estimated $34.2M.
  • Jacobs Levy Equity Management fully exited Nike in Q4 2016, selling an estimated $39.1M.
  • Jacobs Levy Equity Management's ten largest holdings make up 12% of its $5.18B portfolio in Q4 2016.
  • Jacobs Levy Equity Management opened 156 new positions and closed 210 in Q4 2016.
  • Jacobs Levy Equity Management's portfolio value fell 7.5% quarter-over-quarter to $5.18B.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2016, filed 14 Feb 2017.